[Amoxicillin and paracetamol dosing in children: playing safe]
B Peters1, E G P M de Bont, J W L Cals
1Universitair Ziekenhuis Brussel, afd. Algemene Pediatrie, Brussel, België.
Nederlands Tijdschrift Voor Geneeskunde
|September 29, 2016
Summary
Dosing instructions for amoxicillin and paracetamol in children are often unclear due to insufficient evidence. This study proposes weight-based dosing and standardized prescription information for safer medication use in pediatrics.
Area of Science:
- Pediatric Pharmacology
- Evidence-Based Medicine
- Drug Dosing
Background:
- Amoxicillin and paracetamol are frequently prescribed pediatric medications.
- Current dosing guidelines lack scientific evidence, leading to ambiguity.
- Unclear instructions can compromise safe and effective pediatric medication use.
Purpose of the Study:
- To critically evaluate current dosing instructions for amoxicillin and paracetamol in children.
- To advocate for clearer, evidence-based dosing guidelines.
- To propose improvements for the Netherlands' pediatric formulary (Kinderformularium).
Main Methods:
- Review of existing pediatric dosing guidelines and scientific literature.
- Analysis of current practices in pediatric medication prescription.
- Formulation of recommendations for improved dosing and prescription standards.
Main Results:
- Current dosing instructions for amoxicillin and paracetamol are often based on age rather than weight.
- Proposed weight-based dosing: paracetamol 60 mg/kg/day (four divided doses), amoxicillin 60 mg/kg/day (two divided doses).
- Recommended prescription details include daily dose, divided doses, therapy duration, indication, and child's weight.
Conclusions:
- Implementing weight-based dosing and standardized prescription information enhances medication safety in children.
- Clearer guidelines reduce ambiguity and potential errors in pediatric prescribing.
- Aligning the Kinderformularium with daily practice improves medication management for children.
Related Concept Videos
01:29Drug Dosing: Infants and Children
677
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
677
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
349
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
631
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
631
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
312
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
419
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
307
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
307